felbamate and promazine

felbamate has been researched along with promazine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glen, RC; Lowe, R; Mitchell, JB	1
Churchill, GC; Moore, JB; Schymura, Y; Vasudevan, SR	1

Other Studies

2 other study(ies) available for felbamate and promazine

Article	Year
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Shape-based reprofiling of FDA-approved drugs for the H₁ histamine receptor. Journal of medicinal chemistry, 2012, Aug-23, Volume: 55, Issue:16 Topics: Animals; Antidepressive Agents; Brain; Calcium; Chlorprothixene; Databases, Chemical; HeLa Cells; High-Throughput Screening Assays; Histamine; Histamine H1 Antagonists; Humans; Male; Models, Molecular; Molecular Conformation; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; Structure-Activity Relationship; United States; United States Food and Drug Administration	2012

Article

Year

Predicting phospholipidosis using machine learning.

Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010

Shape-based reprofiling of FDA-approved drugs for the H₁ histamine receptor.

Journal of medicinal chemistry, 2012, Aug-23, Volume: 55, Issue:16

Topics: Animals; Antidepressive Agents; Brain; Calcium; Chlorprothixene; Databases, Chemical; HeLa Cells; High-Throughput Screening Assays; Histamine; Histamine H1 Antagonists; Humans; Male; Models, Molecular; Molecular Conformation; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; Structure-Activity Relationship; United States; United States Food and Drug Administration

2012